Versant Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Versant Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-117	Closed	-$11.2K	–	2841
2026 Q2	$11.2K	Sell	117 -49	-30%	-$5.02K	﹤0.01%	2195
2026 Q1	$18.1K	Buy	+166	New	+$15.8K	﹤0.01%	1866
2023 Q3	–	Sell	-12	Closed	-$807	–	2005
2023 Q2	$807	Buy	+12	New	+$732	﹤0.01%	1675
2020 Q1	–	Sell	-10	Closed	–	–	1519
2019 Q4	$0	Hold	10	–	–	﹤0.01%	1481
2019 Q3	$0	Hold	10	–	–	﹤0.01%	1490
2019 Q2	$0	Sell	10 -7	-41%	-$195	﹤0.01%	1567
2019 Q1	$0	Buy	+17	New	+$454	﹤0.01%	1662

Other funds holding LMAT

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

RWS

Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Versant Capital Management's LMAT Position: Q3 2026 in Review

Versant Capital Management sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 117 shares — an estimated $11.2K sold.

Versant Capital Management first reported a position in LMAT in Q1 2019 and held it in 7 quarters. The position peaked at $18.1K in Q1 2026. 7 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

Versant Capital Management reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
Versant Capital Management sold 117 LeMaitre Vascular shares in Q3 2026, an estimated $11.2K.
Versant Capital Management first reported a position in LeMaitre Vascular in Q1 2019 and held it in 7 quarters.
Versant Capital Management's LeMaitre Vascular position peaked at $18.1K in Q1 2026.
7 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.